Retinoid X receptor ligands: a patent review (2007 – 2013)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.24, Iss.4, 2014-04, pp. : 443-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Retinoid X Receptor Ligands with Anti-Type 2 Diabetic Activity

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 6, 2017-01 ,pp. : 696-707

Bentham Science Publishers

Access to resources Recommend Favorite

Estrogen receptor ligands: a patent review update

By Paterni Ilaria Bertini Simone Granchi Carlotta Macchia Marco Minutolo Filippo

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1247-1271

Informa Healthcare

Access to resources Recommend Favorite

Benzodiazepine receptor ligands: a patent review (2006 - 2012)

By Guerrini Gabriella Ciciani Giovanna

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 843-866

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes

By Kintscher U. Goetze S. Wakino S. Kim S. Nagpal S. Chandraratna R.A.S. Graf K. Fleck E. Hsueh W.A. Law R.E.

European Journal of Pharmacology, Vol. 401, Iss. 3, 2000-08 ,pp. : 259-270

Elsevier

Access to resources Recommend Favorite

Nicotinic acetylcholine receptor ligands, a patent review (2006 – 2011)

By Gündisch Daniela Eibl Christoph

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 12, 2011-12 ,pp. : 1867-1896

Informa Healthcare

Access to resources Recommend Favorite